We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$1.1M
Cap. Flow
-$73.9M
Cap. Flow %
-40.89%
Top 10 Hldgs %
71.68%
Holding
125
New
27
Increased
27
Reduced
16
Closed
30

Top Buys

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$2.5M
2
AVTR.PRA
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
+$1.86M
3
DZSI
DZS Inc. Common Stock
DZSI
+$1.79M
4
MU icon
Micron Technology
MU
+$1.09M
5
ASPN icon
Aspen Aerogels
ASPN
+$943K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.73M
2
AMGN icon
Amgen
AMGN
+$2.25M
3
AMSC icon
American Superconductor
AMSC
+$1.34M
4
QCOM icon
Qualcomm
QCOM
+$876K
5
RIG icon
Transocean
RIG
+$635K

Sector Composition

Rank Sector Weight
1 Technology 7.59%
2 Healthcare 5.46%
3 Industrials 2.4%
4 Consumer Discretionary 0.95%
5 Communication Services 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DERM
26
DELISTED
Dermira, Inc.
DERM
$683K 0.38%
71,372
+27,372
+62% +$295K
VGT icon
27
Vanguard Information Technology ETF
VGT
$138B
$680K 0.38%
25,800
+1,632
+7% +$42.1K
DMAC icon
28
DiaMedica Therapeutics
DMAC
$363M
$657K 0.36%
132,514
+12,651
+11% +$43.7K
QUIK icon
29
QuickLogic
QUIK
$228M
$651K 0.36%
80,810
+71,803
+797% +$726K
RFIL icon
30
RF Industries
RFIL
$132M
$646K 0.36%
76,572
– –
RIGL icon
31
Rigel Pharmaceuticals
RIGL
$692M
$595K 0.33%
22,794
+880
+4% +$19.9K
CLFD icon
32
Clearfield
CLFD
$436M
$590K 0.33%
44,498
– –
ADMS
33
DELISTED
Adamas Pharmaceuticals
ADMS
$545K 0.3%
87,908
+28,168
+47% +$162K
DHX icon
34
DHI Group
DHX
$164M
$488K 0.27%
+136,810
New +$475K
LUMO
35
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$483K 0.27%
36,279
+8,985
+33% +$136K
OESX icon
36
Orion Energy Systems
OESX
$41.9M
$460K 0.25%
+15,499
New +$308K
DSPG
37
DELISTED
DSP Group Inc
DSPG
$441K 0.24%
30,721
-16,976
-36% -$245K
QUMU
38
DELISTED
Qumu Corp.
QUMU
$433K 0.24%
+104,359
New +$352K
XLF icon
39
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$414K 0.23%
15,030
+463
+3% +$12.5K
APVO icon
40
Aptevo Therapeutics
APVO
$5.25M
– –
0
– –
FLNA
41
Filana Therapeutics
FLNA
$43.5M
$359K 0.2%
296,623
+8,260
+3% +$9.37K
XLP icon
42
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
$317K 0.18%
5,450
-1,039
-16% -$59.5K
LRMR icon
43
Larimar Therapeutics
LRMR
$398M
$316K 0.18%
+22,129
New +$589K
TVTX icon
44
PUT
Travere Therapeutics
TVTX
$5.27B
$289K 0.16%
185,800
+166,621
+869% +$3.29M
XPH icon
45
State Street SPDR S&P Pharmaceuticals ETF
XPH
$480M
$279K 0.15%
7,011
-1,624
-19% -$63.9K
AQMS icon
46
Aqua Metals
AQMS
$9.78M
$272K 0.15%
+814
New +$359K
IVAC
47
DELISTED
Intevac Inc
IVAC
$271K 0.15%
55,964
+44,500
+388% +$233K
OEF icon
48
PUT
iShares S&P 100 ETF
OEF
$19.8B
$259K 0.14%
50,000
– –
NNDM
49
Nano Dimension
NNDM
$312M
$252K 0.14%
52,466
-93,831
-64% -$582K
CORV
50
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$249K 0.14%
87,257
-84,809
-49% -$217K
1
2
3 4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Worth Venture Partners held 125 positions worth $181M, up 0.61% from $180M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Worth Venture Partners withdrew a net $73.9M in Q2 2019, closing 30 positions and reducing 16 holdings. Its most notable exit was Biogen, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Coherent Inc worth $2.53M.

  • Worth Venture Partners's largest Q2 2019 buy was Coherent Inc: 18,524 shares worth $2.53M.
  • Worth Venture Partners added most to QuickLogic in Q2 2019, an estimated $726K increase.
  • Worth Venture Partners's biggest Q2 2019 reduction was Nano Dimension, cutting an estimated $582K.
  • Worth Venture Partners fully exited Biogen in Q2 2019, selling an estimated $3.73M.
  • Worth Venture Partners's ten largest holdings make up 72% of its $181M portfolio in Q2 2019.
  • Worth Venture Partners opened 27 new positions and closed 30 in Q2 2019.
  • Worth Venture Partners's portfolio value rose 0.61% quarter-over-quarter to $181M.

Based on Worth Venture Partners's 13F filing for Q2 2019, filed 14 Aug 2019.